Related Experiment Videos
Hemolytic uremic syndrome associated with cisplatin therapy
M E Weinblatt1, E Kahn, P G Scimeca
1Department of Pediatrics, Cornell University Medical College, Manhasset, New York.
The American Journal of Pediatric Hematology/Oncology
|January 1, 1987
Abstract:
An adolescent with a small round cell tumor of the chest wall, who was treated with cisplatin, developed hemolytic uremic syndrome with severe hypertension, which ultimately contributed to her death. Cisplatin's role as a possible causative agent of this syndrome is discussed. Recommendations are made for monitoring abnormalities that may signal the onset of this potential complication.